STAAR SURGICAL COSTAAEarnings & Financial Report
Nasdaq · Health Care · Ophthalmic Goods
STAAR Surgical Co is a global ophthalmic medical device firm. It designs, makes and sells implantable collamer lenses (ICLs) for minimally invasive vision correction, plus supporting surgical products for ophthalmologists across North America, Europe, Asia Pacific and other key regional markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Broadwood Partners, L.P. | 22.10% | 10.8M | ▲ +1.40pp | 2024-01-10 |
| BlackRock, Inc. | 15.50% | 7.6M | flat | 2024-11-12 |
| The Vanguard Group | 11.20% | 5.5M | — | 2024-02-13 |
| Nos. of above persons | 3.18% | 1.6M | ▼ -5.93pp | 2024-09-06 |
Insider Transactions
Net 90d: +$12.27M · buys $12.27M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-14 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 19.6K | $0.00 | $0 |
| 2026-03-14 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 9.8K | $0.00 | $0 |
| 2026-03-14 | Magda Michna | Chief Development Officer | Option exercise | 14.7K | $0.00 | $0 |
| 2026-03-14 | Magda Michna | Chief Development Officer | Option exercise | 2.9K | $0.00 | $0 |
| 2026-03-13 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 316.0K | $18.61 | $5.88M |
| 2026-03-13 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 0 | $0.00 | $0 |
| 2026-03-12 | Warren Foust | Interim Co-CEO and Pres. & COO | Option exercise | 8.2K | $0.00 | $0 |
| 2026-03-12 | Magda Michna | Chief Development Officer | Option exercise | 6.2K | $0.00 | $0 |
| 2026-03-12 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 299.4K | $18.12 | $5.42M |
| 2026-03-12 | L.P. BROADWOOD PARTNERS | Director | Buy (open market) | 0 | $0.00 | $0 |
1–10 of 12
Page 1 / 2